Noble Biomaterials
Latest round
- Series C
Last raised
- Jul 2013
Total raised
- $8M
Investors
- 4
About Noble Biomaterials
Noble Biomaterials, Inc.Founded in 1997 and headquartered in Scranton, US, Noble Biomaterials specializes in intelligent materials. The firm has undergone strategic pivots to expand its product lines.Noble Biomaterials specializes in advanced intelligent materials, with a primary focus on innovative product offerings such as Circuitex®, Ionic+®, and X-Static®. These materials are engineered to enhance performance across a range of applications, including energy management, health and medical sectors, and aerospace and defense. Circuitex® serves as a comprehensive energy material that promotes efficient energy harvesting and storage, while Ionic+® provides antimicrobial properties suitable for textiles and medical applications. X-Static®, recognized for its unique silver-based technology, is utilized in performance fabrics to offer odor control and moisture management.Noble Biomaterials generates revenue through a B2B model, engaging primarily with manufacturers and industry partners who incorporate their intelligent materials into consumer products. Transactions typically occur through direct partnerships and supply agreements, enabling clients to utilize Noble's proprietary technologies in their offerings. Pricing structures are established based on contracts that reflect the value and performance benefits of each material, particularly for flagship products such as X-Static® and Circuitex®. These agreements may involve bulk purchasing arrangements or licensing fees, tailored to meet the specific needs of diverse industries.Noble Biomaterials plans to introduce new products designed to enhance their existing offerings, although specific release dates have not been disclosed. The company is targeting expansion into key markets in Asia and Europe by 2025 to tap into growing demand in those regions.00 mn is expected to support these initiatives, enhancing research and development efforts for new product launches and market entry strategies.
Who invested in Noble Biomaterials
4 investors across 2 rounds
See all investors in Noble Biomaterials
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Noble Biomaterials
Who invested in Noble Biomaterials?
Noble Biomaterials has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Noble Biomaterials raised?
Noble Biomaterials has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Noble Biomaterials last raise money?
Noble Biomaterials's most recent round on record is a Series C, in Jul 2013.
What does Noble Biomaterials do?
Noble Biomaterials is a materials company.
Where is Noble Biomaterials headquartered?
Noble Biomaterials is headquartered in Scranton, US.
Which VCs invest in companies like Noble Biomaterials?
Among active investors with capital left to deploy, Kimmeridge, GEF Capital Partners, S2G Ventures and EnCap Investments back materials companies at Noble Biomaterials's stage. Their profiles are linked below.
VCs backing materials startups at Series C
Raising like Noble Biomaterials? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.